Type II DHQD:
Pro105: A unique residue in Corynebacterium glutamicum DHQD near the substrate’s 5-hydroxyl group. Replacement with Ile/Val reduced activity by ~70%, while S103T increased activity by 10% .
Tyr24 and Asp88 (in Mycobacterium tuberculosis DHQD): Critical for stabilizing the enolate intermediate .
N. europaea’s genome (2.8 Mbp, 50.7% GC) encodes 2,460 proteins, including enzymes for ammonia oxidation, CO fixation, and aromatic amino acid metabolism .
While aroQ is not explicitly annotated in current N. europaea genome databases, proteomic studies confirm the presence of shikimate pathway enzymes .
Autotrophic Carbon Fixation: Relies on the Calvin-Benson-Bassham (CBB) cycle, with RuBisCO as the primary CO-fixing enzyme .
Link to Nitrogen Metabolism: DHQD may indirectly support redox balance during ammonia oxidation by producing aromatic precursors for stress-response molecules .
Expression Systems: Escherichia coli is commonly used for heterologous expression of aroQ homologs (e.g., M. tuberculosis) due to high yields and ease of purification .
Kinetic Parameters:
Antimicrobial Targets: Type II DHQD is absent in humans, making it a candidate for drug development against pathogens (e.g., M. tuberculosis) .
Bioremediation: N. europaea’s ability to degrade halogenated compounds (e.g., trichloroethylene) could be enhanced via aroQ engineering .
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type is determined during production. To ensure a specific tag type, please inform us beforehand, and we will prioritize its inclusion.
Catalyzes a trans-dehydration reaction via an enolate intermediate.
KEGG: neu:NE0651
STRING: 228410.NE0651
Nitrosomonas europaea is an obligate chemolithoautotrophic bacterium that derives all its energy and reducing power from the oxidation of ammonia to nitrite. It plays a crucial role in the biogeochemical nitrogen cycle through nitrification, converting reduced nitrogen (ammonia/ammonium) to oxidized forms (nitrite). As a member of the β-subdivision of proteobacteria, N. europaea has the remarkable ability to fix carbon dioxide to meet its carbon requirements while utilizing inorganic nutrients for growth .
The ecological significance of N. europaea extends to multiple environmental processes. While nitrification can produce greenhouse gases (NO and N₂O) and contribute to nitrogen leaching in water bodies, it also increases nitrogen availability to plants, supports wastewater treatment processes, and shows potential for bioremediation of sites contaminated with chlorinated aliphatic hydrocarbons .
The 3-dehydroquinate dehydratase (aroQ) enzyme catalyzes the conversion of 3-dehydroquinic acid (DHQ) to 3-dehydroshikimic acid in the middle stage of the shikimate pathway . This pathway is essential for the biosynthesis of aromatic amino acids (phenylalanine, tyrosine, and tryptophan) and folates, which are vital for cellular function.
In N. europaea, the aroQ enzyme belongs to the type II DHQD family and plays a critical role in the organism's ability to synthesize these essential compounds. Unlike heterotrophic organisms that can acquire aromatic amino acids from their environment, N. europaea must synthesize these compounds de novo due to its autotrophic lifestyle, making the shikimate pathway and the aroQ enzyme particularly important for its survival and growth .
Most notably, N. europaea aroQ possesses a distinctive residue (P105) not conserved in other DHQDs at the position near the 5-hydroxyl group of the substrate . This unique residue may contribute to specific catalytic properties or substrate binding characteristics that differentiate the N. europaea enzyme from its counterparts in other organisms.
Recombinant N. europaea aroQ can be expressed in multiple systems, each offering distinct advantages depending on research objectives:
| Expression System | Advantages | Limitations | Optimal Use Cases |
|---|---|---|---|
| E. coli | High yield, rapid growth, cost-effective, well-established protocols | Limited post-translational modifications, potential inclusion body formation | Initial characterization, structural studies, high-throughput screening |
| Yeast | Eukaryotic post-translational modifications, secretion capabilities, moderate yield | Longer culture time than E. coli, hyperglycosylation possible | Studies requiring certain eukaryotic modifications |
| Baculovirus | Advanced eukaryotic post-translational modifications, high expression levels | Technical complexity, higher cost, longer production time | Complex functional studies, when mammalian-like modifications are required |
| Mammalian cells | Most authentic post-translational modifications, native-like protein folding | Highest cost, lowest yield, technical complexity | Studies focusing on protein-protein interactions or requiring precise modifications |
Optimizing aroQ solubility and activity in heterologous expression systems requires careful consideration of several factors:
Temperature optimization: Lower induction temperatures (16-25°C) often improve protein folding and solubility for bacterial enzymes like aroQ. Conducting small-scale expression trials at varying temperatures (37°C, 30°C, 25°C, 18°C) can help identify optimal conditions.
Induction parameters: The concentration of inducer (e.g., IPTG for E. coli systems) and induction timing significantly impact protein solubility. Lower inducer concentrations (0.1-0.5 mM IPTG) and induction during mid-log phase often yield better results for enzymatic proteins.
Fusion tags selection: For N. europaea aroQ, solubility-enhancing tags like MBP (maltose-binding protein) or SUMO can improve folding. While the product information notes that "tag type will be determined during the manufacturing process," researchers should consider the impact of different tags on downstream applications .
Buffer optimization: The buffer composition during lysis and purification critically affects enzyme stability. For aroQ, buffers containing glycerol (10-20%), reducing agents (1-5 mM DTT or β-mercaptoethanol), and appropriate pH (typically 7.0-8.0) help maintain enzyme stability and activity.
Codon optimization: Adapting the N. europaea aroQ gene sequence to the codon usage bias of the expression host can significantly improve translation efficiency and protein yield, particularly when expressing in evolutionarily distant hosts.
The N. europaea aroQ enzyme belongs to the type II dehydroquinate dehydratase family. The full-length protein consists of 144 amino acids with the amino acid sequence starting with MAANILVIHG and ending with FALTR . Structural analyses reveal that type II DHQDs typically form homo-dodecameric assemblies composed of dimeric units, creating a catalytically active quaternary structure.
The distinctive feature of N. europaea aroQ is the presence of residue P105 near the substrate's 5-hydroxyl group binding site, which is not conserved in other DHQDs . This unique residue may influence substrate binding specificity or catalytic efficiency.
The catalytic mechanism of type II DHQDs involves a base-catalyzed anti-elimination of water across the C1-C6 bond of the substrate. Key catalytic residues typically include a conserved tyrosine that acts as a general base to abstract a proton from C2, and a histidine that facilitates the departure of the hydroxyl group from C1. While the specific catalytic residues in N. europaea aroQ are not explicitly identified in the search results, based on homology with other type II DHQDs, similar mechanisms likely apply.
While the search results don't provide specific kinetic parameters for N. europaea aroQ, a methodological approach to addressing this question would involve:
Expression and purification of both native and recombinant enzymes: Native enzyme would be isolated directly from N. europaea cultures, while recombinant versions would be produced in various expression systems (E. coli, yeast, etc.).
Kinetic parameter determination: Standard enzyme assays would measure Km, kcat, and catalytic efficiency (kcat/Km) using 3-dehydroquinate as substrate.
Comparative analysis: The following table illustrates how such a comparison might be structured:
| Enzyme Source | Km (μM) | kcat (s⁻¹) | kcat/Km (M⁻¹s⁻¹) | Optimal pH | Temperature Optimum (°C) |
|---|---|---|---|---|---|
| Native N. europaea | [value] | [value] | [value] | [value] | [value] |
| Recombinant (E. coli) | [value] | [value] | [value] | [value] | [value] |
| Recombinant (Yeast) | [value] | [value] | [value] | [value] | [value] |
| Other organism 1 | [value] | [value] | [value] | [value] | [value] |
| Other organism 2 | [value] | [value] | [value] | [value] | [value] |
Such a comparison would reveal whether heterologous expression affects enzyme performance and how N. europaea aroQ compares with homologous enzymes from other species, providing insights into potential evolutionary adaptations related to N. europaea's chemolithoautotrophic lifestyle.
The optimal conditions for assaying N. europaea aroQ activity should be established through systematic parameter optimization:
Buffer composition: A standard assay buffer would typically contain:
50 mM Tris-HCl or phosphate buffer (pH 7.0-8.0)
100-150 mM NaCl for ionic strength
1-5 mM DTT or β-mercaptoethanol as reducing agent
5-10% glycerol for stability
pH optimization: The activity should be tested across a pH range (5.0-9.0) to determine the optimum. Type II DHQDs typically show maximal activity in the pH range of 7.0-8.0.
Temperature range: Activity measurements at temperatures ranging from 25-50°C would help identify the temperature optimum, with consideration of N. europaea's natural growth conditions.
Substrate concentration: A range of 3-dehydroquinate concentrations (typically 10 μM to 1 mM) should be tested to establish Michaelis-Menten kinetics.
Detection methods: Activity can be monitored by:
Spectrophotometric measurement of product formation at 234 nm (absorption maximum of the unsaturated product)
HPLC analysis of substrate consumption and product formation
Coupled enzyme assays that link product formation to a colorimetric or fluorometric readout
When designing assays, it's important to consider the unique metabolic context of N. europaea, which functions in an ammonia-oxidizing environment with specific oxygen requirements .
Designing effective site-directed mutagenesis experiments for N. europaea aroQ requires a systematic approach:
Target residue identification: Focus on:
Mutagenesis strategy:
Conservative substitutions: Replace with amino acids of similar properties to probe subtle effects
Non-conservative substitutions: Replace with functionally distinct amino acids to test essential nature
Alanine scanning: Systematically replace residues with alanine to eliminate side-chain functions
Experimental validation framework:
Express and purify mutant proteins under identical conditions
Assess structural integrity through circular dichroism or thermal stability assays
Determine kinetic parameters (Km, kcat) for each mutant
Evaluate quaternary structure through analytical ultracentrifugation or size-exclusion chromatography
Data analysis template:
| Mutation | Expression Level | Structural Impact | Km (μM) | kcat (s⁻¹) | kcat/Km (M⁻¹s⁻¹) | Oligomeric State |
|---|---|---|---|---|---|---|
| Wild-type | [baseline] | [baseline] | [value] | [value] | [value] | [state] |
| P105A | [% of WT] | [observation] | [value] | [value] | [value] | [state] |
| P105S | [% of WT] | [observation] | [value] | [value] | [value] | [state] |
| [Cat1]A | [% of WT] | [observation] | [value] | [value] | [value] | [state] |
This methodical approach would provide insights into the specific roles of residues unique to N. europaea aroQ, potentially revealing adaptations related to the organism's unusual metabolism as an ammonia oxidizer .
Recent research has explored the effects of simulated microgravity (SMG) on N. europaea in tripartite communities with Comamonas testosteroni and Nitrobacter winogradskyi . Building on this foundation, recombinant N. europaea aroQ could serve as a model system for investigating microgravity effects on metabolic pathways:
Comparative enzyme activity studies:
Express and purify recombinant N. europaea aroQ under normal gravity (NG) and simulated microgravity (SMG) conditions
Compare enzyme kinetics, stability, and structural properties
Assess the impact of microgravity on post-translational modifications that might affect catalytic activity
Integration with transcriptomics data:
Experimental design for space station experiments:
Use recombinant aroQ as a model enzyme for pre-flight testing
Design stabilized enzyme formulations suitable for spaceflight experiments
Create biosensor systems using aroQ to monitor shikimate pathway activity in real-time during spaceflight
This approach would provide valuable insights into how microgravity affects essential metabolic pathways in bacteria relevant to regenerative life support systems (RLSS) for long-duration space missions. The existing research showing that N. europaea comprised approximately 19-23% of the tripartite community under different gravity conditions provides context for interpreting aroQ-specific effects .
N. europaea aroQ can serve as a molecular probe for investigating nutrient limitation responses in chemolithoautotrophs, providing insights into metabolic adaptations:
| Nutrient Limitation | Growth Rate | aroQ mRNA Level | aroQ Protein Level | Enzyme Activity | Aromatic AA Pools |
|---|---|---|---|---|---|
| None (control) | [value] | [value] | [value] | [value] | [value] |
| Ammonia limitation | [value] | [value] | [value] | [value] | [value] |
| CO₂ limitation | [value] | [value] | [value] | [value] | [value] |
| Phosphate limitation | [value] | [value] | [value] | [value] | [value] |
| O₂ limitation | [value] | [value] | [value] | [value] | [value] |
This research would provide insights into how specialized organisms like N. europaea balance competing metabolic demands under resource constraints, with potential applications to bioremediation and wastewater treatment where these organisms often face variable nutrient conditions .
The distinctive P105 residue in N. europaea aroQ provides a unique opportunity for enzyme engineering applications :
Substrate specificity engineering:
The unique P105 residue near the substrate's 5-hydroxyl group binding site could be exploited to alter substrate recognition
Creating a library of P105X mutations might yield variants with altered specificity for modified substrates
This could enable the enzymatic production of novel shikimate pathway intermediates for pharmaceutical applications
Stability enhancement strategies:
Proline residues often contribute to protein rigidity and thermostability
The distinctive P105 might be part of a structural feature that could be leveraged to enhance stability
Combining P105 modifications with additional stabilizing mutations could yield enzymes suitable for industrial applications
Methodological approach to P105-focused engineering:
Create a comprehensive P105X library (all 19 possible amino acid substitutions)
Develop high-throughput screening methods to assess activity on standard and modified substrates
Characterize promising variants through detailed kinetic and structural analyses
Use computational modeling to predict additional modifications that might synergize with P105 alterations
Potential applications in synthetic biology:
Engineered aroQ variants could be incorporated into synthetic pathways for producing high-value aromatic compounds
N. europaea's chemolithoautotrophic metabolism provides a unique context that might be advantageous for certain bioproduction scenarios
Combining aroQ engineering with whole-cell approaches could yield novel biocatalysts for environmental applications
This research direction would build upon the structural insights into N. europaea aroQ while leveraging the organism's unique metabolic capabilities as an ammonia oxidizer .
Several significant research gaps remain in understanding how the shikimate pathway (including aroQ) integrates with nitrogen metabolism in N. europaea:
Regulatory interconnections:
How nitrogen availability affects shikimate pathway enzyme expression and activity remains poorly characterized
The potential role of transcriptional regulators that respond to both nitrogen status and aromatic amino acid pools needs investigation
Metabolic flux distribution:
How N. europaea balances carbon allocation between central metabolism and the shikimate pathway under different ammonia oxidation rates is unclear
Quantitative metabolic flux analysis under various nitrogen conditions would provide valuable insights
Energy coupling mechanisms:
Research methodology approaches:
Multi-omics integration: Combine transcriptomics, proteomics, and metabolomics to track pathway responses to environmental changes
Isotope labeling studies: Use ¹³C and ¹⁵N labeled substrates to track atomic flows between nitrogen and carbon metabolism
Genetic manipulation: Develop improved genetic tools for N. europaea to enable precise modification of regulatory elements
Proposed experimental framework:
| Research Question | Experimental Approach | Expected Outcomes | Broader Implications |
|---|---|---|---|
| How does ammonia availability affect aroQ expression? | qRT-PCR and proteomic analysis across ammonia concentrations | Correlation between N availability and shikimate pathway regulation | Insight into autotroph resource allocation |
| What transcription factors regulate aroQ? | ChIP-seq and DNA binding assays | Identification of regulatory proteins | Potential targets for metabolic engineering |
| How is carbon partitioned between shikimate pathway and other needs? | ¹³C flux analysis under varying ammonia oxidation rates | Quantitative flux maps | Understanding of chemolithoautotroph metabolic strategies |
Addressing these gaps would enhance our understanding of how specialized organisms like N. europaea coordinate essential biosynthetic pathways with their unusual energy metabolism, potentially informing applications in bioremediation, wastewater treatment, and synthetic biology .